These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6884355)

  • 1. Change in the reactivity of the active-site serine OH of butyrylcholinesterase caused by a new reversible inhibitor.
    Gaál J; Bartha F; Batke J
    Eur J Biochem; 1983 Sep; 135(1):157-62. PubMed ID: 6884355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of dibenzodioxazocines and their effects on cholinesterases and muscarinic cholinergic receptors.
    Gaál J; Batke J; Borsodi A; Rózsa L; Somogyi G
    Acta Biochim Biophys Hung; 1989; 24(1-2):129-42. PubMed ID: 2514534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphobutyrylcholinesterase: phosphorylation of the esteratic site of butyrylcholinesterase by ethephon [(2-chloroethyl)phosphonic acid] dianion.
    Haux JE; Quistad GB; Casida JE
    Chem Res Toxicol; 2000 Jul; 13(7):646-51. PubMed ID: 10898597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The peptidase site of butyrylcholinesterase is distinct from the esterase site].
    Chatonnet A; Masson P
    C R Acad Sci III; 1984; 299(13):529-34. PubMed ID: 6208983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the peptidasic site of cholinesterase: preliminary results.
    Chatonnet A; Masson P
    FEBS Lett; 1985 Mar; 182(2):493-8. PubMed ID: 2579854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic model for butyrylcholinesterase.
    Eriksson H; Augustinsson KB
    Biochim Biophys Acta; 1979 Mar; 567(1):161-73. PubMed ID: 454620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of two monomeric butyrylcholinesterases from rabbit liver by chlorpromazine and other drugs.
    Rush RS; Main AR; Kilpatrick BF; Faulkner GD
    J Pharmacol Exp Ther; 1981 Mar; 216(3):586-91. PubMed ID: 7205639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging of di-isopropyl-phosphorylated human butyrylcholinesterase.
    Masson P; Fortier PL; Albaret C; Froment MT; Bartels CF; Lockridge O
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):601-7. PubMed ID: 9359435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of new muscarinergic dibenzodioxazocines.
    Kálmán A; Párkányi L; Valkó K; Mátrai G; Batke J; Gaál J
    Acta Biochim Biophys Hung; 1989; 24(1-2):143-58. PubMed ID: 2514535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reactivity of active sites in human plasma cholinesterase toward 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
    Ozer N; Ozer I
    Arch Biochem Biophys; 1987 May; 255(1):89-94. PubMed ID: 3592672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective inhibition of human butyrylcholinesterase by phosphonothiolate analogs of (+)- and (-)-cocaine.
    Berkman CE; Underiner GE; Cashman JR
    Biochem Pharmacol; 1997 Dec; 54(11):1261-6. PubMed ID: 9416977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Binding of reversible spin-labeled inhibitors with an butyrylcholinesterase active center].
    Dorokhov KE; Grigorian GL
    Biofizika; 1986; 31(5):746-51. PubMed ID: 3022829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-dependent kinetic behavior of horse plasma cholinesterase: evidence for kinetically distinct populations of active sites.
    Söylemez Z; Ozer I
    Arch Biochem Biophys; 1984 Dec; 235(2):650-6. PubMed ID: 6517605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catalytic properties of cholinesterases immobilized in N-phthalylchitosan and gelatin].
    Kuznetsova LP; Nikol'skaia EB
    Ukr Biokhim Zh (1978); 1995; 67(5):49-54. PubMed ID: 8830436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cetyltrimethylammonium on the human blood cholinesterases activity].
    Kuznetsova LP; Samokish VA; Sochilina EE
    Ukr Biokhim Zh (1999); 2011; 83(2):29-35. PubMed ID: 21851044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction of spin-labeled methacyne analog with butyrylcholinesterase].
    Dorokhov KE; Grigorian GL; Kardanov NA; Zhdanov RI; Trifonova SA
    Biofizika; 1985; 30(1):23-6. PubMed ID: 2983779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P hydrolysis by human serum cholinesterase.
    Lockridge O
    J Neurochem; 1982 Jul; 39(1):106-10. PubMed ID: 6177830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the butyrylcholinesterase by ethidium bromide.
    Patocka J
    Biomed Biochim Acta; 1987; 46(11):769-74. PubMed ID: 3446203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate dependence of amiloride- and soman-induced conformation changes of butyrylcholinesterase as evidenced by high-pressure perturbation.
    Cléry C; Heiber-Langer I; Channac L; David L; Balny C; Masson P
    Biochim Biophys Acta; 1995 Jul; 1250(1):19-28. PubMed ID: 7612649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.